Paydirt
NP
Insider

Nick Pizzie

Chief Financial Officer

Nick Pizzie (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $7.9M of AXSM (33,000 sh × $240.09, as filed), executed Jun 9.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.2M
shares × price, as filed
Last traded
Jun 9
Filed Jun 9

Median ADV $188.5M across their filed names

Open performance
Volume by month
$7.9M$4.0M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $2.0MJan 2026 · sells $2.3MJun 2026 · sells $7.9M
Buys $0 Sells $12.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
AXSM Axsome Therapeutics, Inc. AXSM · 0 buys · 3 sells 3 filings
Recent filings
AXSMSALE Axsome Therapeutics, Inc. View filing → $7.9M
33,000 sh × $240.09
Exec Jun 9
Filed Jun 9 · 5:30 PM ET
AXSMSALE Axsome Therapeutics, Inc. View filing → $2.3M
12,000 sh × $187.92
Exec Jan 22
Filed Jan 23 · 5:30 PM ET
AXSMSALE Axsome Therapeutics, Inc. View filing → $2.0M
15,000 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET